Evaluating overall survival and competing risks of death in patients with localized renal cell carcinoma using a comprehensive nomogram

Journal of Clinical Oncology

Volumn 28, Issue 2, 2010, Pages 311-317

  Kutikov, Alexander ^a   Egleston, Brian L ^a   Wong, Yu Ning ^a   Uzzo, Robert G ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER MORTALITY; CANCER RISK; CANCER SURGERY; CAUSE OF DEATH; CONTROLLED STUDY; DATA BASE; FEMALE; HUMAN; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; NOMOGRAM; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RACE DIFFERENCE; TUMOR VOLUME; AGE; CANCER REGISTRY; COMORBIDITY; KIDNEY TUMOR; MIDDLE AGED; MORTALITY; PATHOLOGY; PROBABILITY; RISK ASSESSMENT; SEX DIFFERENCE;

AGE FACTORS; AGED; CARCINOMA, RENAL CELL; CAUSE OF DEATH; COMORBIDITY; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NOMOGRAMS; PROBABILITY; RISK ASSESSMENT; SEER PROGRAM; SEX FACTORS;

EID: 74949142102     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2009.22.4816     Document Type: Article

References (42)

1. Chawla SN, Crispen PL, Hanlon AL, et al: The natural history of observed enhancing renal masses: Meta-analysis and review of the world literature. J Urol 175:425-431, 2006
2. Hollingsworth JM, Miller DC, Daignault S, et al: Rising incidence of small renal masses: A need to reassess treatment effect. J Natl Cancer Inst 98:1331-1334, 2006
3. Parsons JK, Schoenberg MS, Carter HB: Incidental renal tumors: Casting doubt on the efficacy of early intervention. Urology 57:1013-1015, 2001
4. Kunkle DA, Egleston BL, Uzzo RG: Excise, ablate or observe: The small renal mass dilemma - A meta-analysis and review. J Urol 179:1227-1233, 2008
5. Lane BR, Babineau D, Kattan MW, et al: A preoperative prognostic nomogram for solid enhancing renal tumors 7 cm or less amenable to partial nephrectomy. J Urol 178:429-434, 2007
6. Kunkle DA, Crispen PL, Chen DY, et al: Enhancing renal masses with zero net growth during active surveillance. J Urol 177:849-853, 2007
7. Kunkle DA, Haas NB, Uzzo RG: Adjuvant therapy for high-risk renal cell carcinoma patients. Curr Urol Rep 8:19-30, 2007
8. Crispen PL, Viterbo R, Fox EB, et al: Delayed intervention of sporadic renal masses undergoing active surveillance. Cancer 112:1051-1057, 2008
9. Kouba E, Smith A, McRackan D, et al: Watchful waiting for solid renal masses: Insight into the natural history and results of delayed intervention. J Urol 177:466-470, 2007
10. National Cancer Institute, Division of Cancer Control and Population Sciences Surveillance Research Program Cancer Statistics Branch: Surveillance, Epidemiology, and End Results (SEER) Program Limited Use Data (1973-2004): Released April 2007 (revised September 2007), based on the November 2006 submission. http://seer.cancer.gov/data/
11. Gray RJ: A class of k-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 16:1141-1154, 1988
12. Fine JP, Gray RJ: A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94:496-509, 1999
13. Egleston B, Wong YN: Sensitivity analysis to investigate the impact of a missing covariate on survival analyses using cancer registry data. Stat Med 28:1498-1511, 2009
14. Harrell FE: Regression Modeling Strategies: General Aspects of Fitting Regression Models. New York, NY, Springer, 2001
15. Kattan MW, Heller G, Brennan MF: A competing-risks nomogram for sarcoma-specific death following local recurrence. Stat Med 22:3515-3525, 2003
16. Chow WH, Devesa SS, Warren JL, et al: Rising incidence of renal cell cancer in the United States. JAMA 281:1628-1631, 1999
17. Lamb GWA, Bromwich EJ, Vasey P, et al: Management of renal masses in patients medically unsuitable for nephrectomy: Natural history, complications, and outcome. Urology 64:909-913, 2004
18. Jemal A, Siegel R, Ward E, et al: Cancer statistics, 2008. CA Cancer J Clin 58:71-96, 2008
19. Frank I, Blute ML, Leibovich BC, et al: Independent validation of the 2002 American Joint Committee on cancer primary tumor classification for renal cell carcinoma using a large, single institution cohort. J Urol 173:1889-1892, 2005
20. Frank I, Blute ML, Cheville JC, et al: Solid renal tumors: An analysis of pathological features related to tumor size. J Urol 170:2217-2220, 2003
21. Rothman J, Egleston B, Wong, et al: Histopathological characteristics of localized renal cell carcinoma correlate with tumor size: A SEER analysis. J Urol 181:29-33, 2009
22. Kunkle DA, Uzzo RG: Cryoablation or radiofrequency ablation of the small renal mass: A metaanalysis. Cancer 113:2671-2680, 2008
23. Kim HL, Seligson D, Liu X, et al: Using protein expressions to predict survival in clear cell renal carcinoma. Clin Cancer Res 10:5464-5471, 2004
24. Frank I, Blute ML, Cheville JC, et al: An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: The SSIGN score. J Urol 168:2395-2400, 2002
25. Karakiewicz PI, Briganti A, Chun FKH, et al: Multi-institutional validation of a new renal cancerspecific survival nomogram. J Clin Oncol 25:1316-1322, 2007
26. Kattan MW, Reuter V, Motzer RJ, et al: A postoperative prognostic nomogram for renal cell carcinoma. J Urol 166:63-67, 2001
27. Patard JJ, Leray E, Rioux-Leclercq N, et al: Prognostic value of histologic subtypes in renal cell carcinoma: A multicenter experience. J Clin Oncol 23:2763-2771, 2005
28. Zisman A, Pantuck AJ, Dorey F, et al: Mathematical model to predict individual survival for patients with renal cell carcinoma. J Clin Oncol 20:1368-1374, 2002
29. Zisman A, Pantuck AJ, Wieder J, et al: Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma. J Clin Oncol 20:4559-4566, 2002
30. Zisman A, Pantuck AJ, Dorey F, et al: Improved prognostication of renal cell carcinoma using an integrated staging system. J Clin Oncol 19:1649-1657, 2001
31. Kim HL, Seligson D, Liu X, et al: Using tumor markers to predict the survival of patients with metastatic renal cell carcinoma. J Urol 173:1496-1501, 2005
32. Thompson RH, Leibovich BC, Lohse CM, et al: Dynamic outcome prediction in patients with clear cell renal cell carcinoma treated with radical nephrectomy: The D-SSIGN score. J Urol 177:477-480, 2007
33. Cindolo L, De La Taille A, Messina G, et al: A preoperative clinical prognostic model for nonmetastatic renal cell carcinoma. BJU Int 92:901-905, 2003
34. Yaycioglu O, Roberts WW, Chan T, et al: Prognostic assessment of nonmetastatic renal cell carcinoma: A clinically based model. Urology 58:141-145, 2001
35. Raj GV, Thompson RH, Leibovich BC, et al: Preoperative nomogram predicting 12-year probability of metastatic renal cancer. J Urol 179:2146-2151, 2008
36. Albertsen PC, Hanley JA, Gleason DF, et al: Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer. JAMA 280:975-980, 1998
37. Cowen ME, Halasyamani LK, Kattan MW: Predicting life expectancy in men with clinically localized prostate cancer. J Urol 175:99-103, 2006
38. Walz J, Gallina A, Saad F, et al: A nomogram predicting 10-year life expectancy in candidates for radical prostatectomy or radiotherapy for prostate cancer. J Clin Oncol 25:3576-3581, 2007
39. Arrontes DS, Acenero MJ, Gonzalez JI, et al: Survival analysis of clear cell renal carcinoma according to the Charlson comorbidity index. J Urol 179:857-861, 2008
40. Hollingsworth JM, Miller DC, Daignault S, et al: Five-year survival after surgical treatment for kidney cancer: A population-based competing risk analysis. Cancer 109:1763-1768, 2007
41. Gettman MT, Boelter CW, Cheville JC, et al: Charlson co-morbidity index as a predictor of outcome after surgery for renal cell carcinoma with renal vein, vena cava or right atrium extension. J Urol 169:1282-1286, 2003
42. Kircher T, Nelson J, Burdo H: The autopsy as a measure of accuracy of the death certificate. N Engl J Med 313:1263-1269, 1985